Drug Type Exosomes, siRNA |
Synonyms iExosomes, Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA(Codiak BioSciences), MSC-derived Exosomes with KrasG12D siRNA(Codiak BioSciences) |
Target |
Action inhibitors |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic Pancreatic Cancer | Phase 2 | United States | 27 Jan 2021 | |
| Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | United States | 27 Jan 2021 | |
| Pancreatic adenocarcinoma metastatic | Phase 2 | United States | 27 Jan 2021 |





